Should inhomogeneity corrections be applied during treatment planning of tangential breast irradiation?
- PMID: 1792314
- DOI: 10.1016/0167-8140(91)90156-b
Should inhomogeneity corrections be applied during treatment planning of tangential breast irradiation?
Abstract
Due to the inclusion of lung tissue in the treatment volume, some parts of the breast will get a higher dose during tangential breast irradiation because of the lower lung density. Data on the accuracy of dose calculation algorithms, investigated by phantom measurements, determinations of the geometry and density of the actual lung in the patient and the results of in vivo dose measurements, are presented. From this information it can be concluded that a lung correction varying between about 3% and 7% is needed but its magnitude is slightly overpredicted in a number of commercial treatment planning systems. Because this increase in dose is already in a high dose region, it is recommended that inhomogeneity corrections should be applied during tangential breast irradiation.
Similar articles
-
Intensity modulation to improve dose uniformity with tangential breast radiotherapy: initial clinical experience.Int J Radiat Oncol Biol Phys. 2000 Dec 1;48(5):1559-68. doi: 10.1016/s0360-3016(00)01396-1. Int J Radiat Oncol Biol Phys. 2000. PMID: 11121662
-
Superficial dose distribution in breast for tangential radiation treatment, Monte Carlo evaluation of Eclipse algorithms in case of phantom and patient geometries.Radiother Oncol. 2012 Jan;102(1):102-7. doi: 10.1016/j.radonc.2011.06.021. Epub 2011 Jul 7. Radiother Oncol. 2012. PMID: 21741719
-
Dosimetric analysis of intact breast irradiation in off-axis planes.Int J Radiat Oncol Biol Phys. 1997 Aug 1;39(1):261-7. doi: 10.1016/s0360-3016(97)00292-7. Int J Radiat Oncol Biol Phys. 1997. PMID: 9300762
-
Three-dimensional dose distribution of tangential breast treatment: a national dosimetry intercomparison.Radiother Oncol. 1991 Dec;22(4):252-60. doi: 10.1016/0167-8140(91)90159-e. Radiother Oncol. 1991. PMID: 1792317 Review.
-
In vivo dosimetry during tangential breast treatment.Radiother Oncol. 1991 Dec;22(4):269-79. doi: 10.1016/0167-8140(91)90162-a. Radiother Oncol. 1991. PMID: 1792320 Review.
Cited by
-
Breast dose heterogeneity in CT-based radiotherapy treatment planning.J Med Phys. 2008 Apr;33(2):43-8. doi: 10.4103/0971-6203.41191. J Med Phys. 2008. PMID: 19893689 Free PMC article.
-
Computed tomography imaging parameters for inhomogeneity correction in radiation treatment planning.J Med Phys. 2016 Jan-Mar;41(1):3-11. doi: 10.4103/0971-6203.177277. J Med Phys. 2016. PMID: 27051164 Free PMC article. Review.
-
Quality assurance in a phase III, multicenter, randomized trial of POstmastectomy radioThErapy in Node posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a planning benchmark case.Radiat Oncol. 2023 Nov 29;18(1):194. doi: 10.1186/s13014-023-02379-1. Radiat Oncol. 2023. PMID: 38031125 Free PMC article. Clinical Trial.
-
Quality assurance of the EORTC Trial 22881/10882: boost versus no boost in breast conserving therapy. An overview.Strahlenther Onkol. 1997 Apr;173(4):201-7. doi: 10.1007/BF03039289. Strahlenther Onkol. 1997. PMID: 9111608 Clinical Trial.
-
Anthropomorphic breast phantoms for quality assurance and dose verification.J Appl Clin Med Phys. 2004 Winter;5(1):36-49. doi: 10.1120/jacmp.v5i1.1992. Epub 2004 Jan 1. J Appl Clin Med Phys. 2004. PMID: 15753932 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical